# Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment

> **NCT04534699** · PHASE1 · COMPLETED · sponsor: **KBP Biosciences** · enrollment: 12 (actual)

## Conditions studied

- Moderate Hepatic Impairment
- Healthy

## Interventions

- **DRUG:** KBP-5074

## Key facts

- **NCT ID:** NCT04534699
- **Lead sponsor:** KBP Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-27
- **Primary completion:** 2020-11-19
- **Final completion:** 2020-11-19
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04534699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04534699, "Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04534699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*